Maternal serum soluble HLA-G levels in missed abortions
- PMID: 24709785
Maternal serum soluble HLA-G levels in missed abortions
Abstract
BACKGROUND AND OBJECTIVE. It is unclear how immune tolerance develops to a semiallograft fetus in pregnancy. Human leukocyte antigen G (HLA-G) expressed by extravascular trophoblasts plays an important role in the recognition of the gestational tissues as self and the development of immune tolerance against the gestational tissues by the maternal immune system. The soluble form of the HLA-G (sHLA-G) molecule in the maternal serum is also reported to contribute to the prevention of rejection during pregnancy. The aim of the study was to compare the maternal serum sHLA-G levels of the women with missed abortions and control subjects with uncomplicated pregnancies. MATERIAL AND METHODS. The prospective cross-sectional study involving 40 with missed abortions and 40 control women, matched by age, gestational age, and body mass index, was carried out. The study group consisted of the women with singleton pregnancies, who were diagnosed with a missed abortion. Only the patients who were confirmed to have an uncomplicated term delivery during follow-up were included in the control group. The serum sHLA-G level was compared between the groups. RESULTS. There was no significant difference in the mean serum sHLA-G levels in terms of gravidity (P=0.761) and a history of abortion (P=0.379) in the control group. The median serum sHLA-G level in the missed abortion group was significantly lower compared with the control group (16.8 [8.5-35.8] vs. 26 [11-135] U/mL, P<0.001). All the women in the control group had uncomplicated term deliveries. CONCLUSION. Our results showed that the women with missed abortions had significantly lower serum sHLA-G levels compared with the healthy pregnant controls, which may have potentially played a role in the impairment of physiological immunological tolerance during pregnancy. However, the determination of the exact role and the potential clinical utility of maternal serum sHLA-G for the detection/prediction of a missed abortion risk requires further detailed studies.
Similar articles
-
Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.Am J Reprod Immunol. 2009 Nov;62(5):320-38. doi: 10.1111/j.1600-0897.2009.00742.x. Am J Reprod Immunol. 2009. PMID: 19811467
-
sHLA-G1 and HLA-G5 levels are decreased in Tunisian women with multiple abortion.Hum Immunol. 2016 Apr;77(4):342-5. doi: 10.1016/j.humimm.2016.01.019. Epub 2016 Jan 23. Hum Immunol. 2016. PMID: 26812178
-
Human leukocyte antigen (HLA)-G during pregnancy part I: correlations between maternal soluble HLA-G at midterm, at term, and umbilical cord blood soluble HLA-G at term.Hum Immunol. 2015 Apr;76(4):254-9. doi: 10.1016/j.humimm.2015.01.013. Epub 2015 Jan 28. Hum Immunol. 2015. PMID: 25636573
-
Soluble monomers, dimers and HLA-G-expressing extracellular vesicles: the three dimensions of structural complexity to use HLA-G as a clinical biomarker.HLA. 2016 Sep;88(3):77-86. doi: 10.1111/tan.12844. Epub 2016 Jul 21. HLA. 2016. PMID: 27440734 Review.
-
New insights into HLA-G and inflammatory diseases.Inflamm Allergy Drug Targets. 2012 Dec;11(6):448-63. doi: 10.2174/187152812803590037. Inflamm Allergy Drug Targets. 2012. PMID: 22931388 Review.
Cited by
-
Regulatory T Cells in Pregnancy: It Is Not All About FoxP3.Front Immunol. 2020 Jun 23;11:1182. doi: 10.3389/fimmu.2020.01182. eCollection 2020. Front Immunol. 2020. PMID: 32655556 Free PMC article. Review.
-
HLA-G Expression/Secretion and T-Cell Cytotoxicity in Missed Abortion in Comparison to Normal Pregnancy.Int J Mol Sci. 2024 Feb 24;25(5):2643. doi: 10.3390/ijms25052643. Int J Mol Sci. 2024. PMID: 38473890 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials